8-K current report · filed Oct 9, 2026

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) 8-K Current Report: October 9, 2026

Item 7.01Item EX-99.1CLOV overview

Short answer

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) filed an 8-K current report with the SEC on October 9, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). 2027 CMS Star Ratings: 5 Stars for Clover’s PPO MA plans and 4.5 Stars for its HMO plan.

CLOVER HEALTH INVESTMENTS, CORP. /DE 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • 2027 CMS Star Ratings: 5 Stars for Clover’s PPO MA plans and 4.5 Stars for its HMO plan
  • Ratings affect payment year 2028, supporting future Medicare Advantage reimbursement
  • PPO rating reflects removal of 20 court-disputed measures under an appealed May 27, 2026 decision
  • Including those measures, PPO plans would have received 4.5 Stars, creating regulatory and reimbursement risk

Item EX-99.1 · Exhibit EX-99.1

  • CMS awarded Clover’s PPO MA plans 5 Stars and HMO plan 4.5 Stars for 2027, affecting payment year 2028
  • 5-Star PPO status enables year-round enrollment, supporting membership growth and improved acquisition flexibility
  • Medicare Advantage membership exceeded 157,000, up approximately 48% year over year through first-half 2026
  • PPO rating depends on litigation methodology: 4.5 Stars with 20 disputed measures included, versus 5 Stars excluding them
  • HEDIS score 4.82 out of 5, ranking #1 among qualifying non-SNP PPO plans and supporting quality-based differentiation

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other CLOVER HEALTH INVESTMENTS, CORP. /DE 8-K filings

Get the next CLOV 8-K as it lands

Follow CLOV for push alerts, or ask the research agent what this filing means.